Molecular detection and parasite load of Trypanosoma cruzi in digestive tract tissue of Chagas disease patients affected by megacolon.


Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 25 03 2022
revised: 01 08 2022
accepted: 02 08 2022
pubmed: 7 8 2022
medline: 14 9 2022
entrez: 6 8 2022
Statut: ppublish

Résumé

Chagas disease, caused by the Trypanosoma cruzi parasite in the Americas affects ∼ 7 million people, 30% with cardiac tissue damage and 10-15% with digestive disorders. In this study, we have developed a protocol to detect the presence of the parasite and estimate its load in resected dysfunctional tissue segments of chronically infected patients with digestive megacolon. We have included samples from 43 individuals, 38/5 with positive/negative serology for Chagas disease and digestive syndromes. Samples of 1.5 to 2.0 cm

Identifiants

pubmed: 35932843
pii: S0001-706X(22)00324-2
doi: 10.1016/j.actatropica.2022.106632
pii:
doi:

Substances chimiques

DNA, Satellite 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106632

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lilian Pinto (L)

Science and Applied Development Studies in Health and the Environment (CEADES) Foundation, Cochabamba, Bolivia. Electronic address: prlilian046@gmail.com.

Alejandro G Schijman (AG)

Laboratory of Molecular Biology of Chagas Disease, Institute for Research in Genetic Engineering and Molecular Biology (INGEBI-CONICET), Buenos Aires, Argentina.

Julio Alonso-Padilla (J)

Barcelona Institute for Global Health (ISGlobal), Hospital Clinic - University of Barcelona, Barcelona 08036, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain.

Daniel Lozano (D)

Science and Applied Development Studies in Health and the Environment (CEADES) Foundation, Cochabamba, Bolivia; Faculty of Medicine, Universidad Mayor de San Simón, Cochabamba, Bolivia.

Mary Cruz Torrico (MC)

Faculty of Medicine, Universidad Mayor de San Simón, Cochabamba, Bolivia.

Pietro Gamba (P)

Pietro Gamba Foundation Anzaldo, Cochabamba, Bolivia.

Margarita Torrez (M)

Pietro Gamba Foundation Anzaldo, Cochabamba, Bolivia.

Vania Lozada (V)

Institute of Gastroenterology Bolivian Japanese, Cochabamba, Bolivia.

Karina Cartagena (K)

Institute of Gastroenterology Bolivian Japanese, Cochabamba, Bolivia.

Jareth Sanchez (J)

Hospital "Dr. Manuel Ascencio Villarroel", Punata, Cochabamba, Bolivia.

Faustino Torrico (F)

Science and Applied Development Studies in Health and the Environment (CEADES) Foundation, Cochabamba, Bolivia; Faculty of Medicine, Universidad Mayor de San Simón, Cochabamba, Bolivia.

Joaquim Gascon (J)

Barcelona Institute for Global Health (ISGlobal), Hospital Clinic - University of Barcelona, Barcelona 08036, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain. Electronic address: quim.gascon@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH